Class Action Signal

Class Action Signal

Class ActionsNews
Class ActionsNewsAboutContact
Public case information

Zoetis Investor Securities Class Action

Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.

Zoetis · Animal-health products, including Librela, Simparica Trio, Apoquel, and Cytopoint · Ongoing Litigation

Last updated

About this case

The filed securities fraud class action alleges that Zoetis and related defendants made materially false or misleading statements and omissions about the company’s business operations, growth prospects, and financial stability, allegedly causing Zoetis securities to trade at artificially inflated prices. The matter is ongoing, and the stated deadline to seek appointment as lead plaintiff was July 27, 2026.

Case overview

Defendant company
Zoetis
Product or service
Animal-health products, including Librela, Simparica Trio, Apoquel, and Cytopoint
Case name
Zoetis Securities Class Action
Court case number
1:26-cv-04401
Case status
Ongoing Litigation
Lawsuit type
Securities
Reported harm
Misrepresentation

Important dates

Lead Plaintiff Application
Zoetis Lead Plaintiff Application

Participation information

Availability is based on each listed participation option and its deadline.

Lead Plaintiff Application

Investors who purchased Zoetis securities during the alleged class period may have been able to seek appointment as lead plaintiff; the article does not specify the class period or other eligibility details.

Papers seeking appointment as lead plaintiff were required to be filed by July 27, 2026.

Type
Lead Plaintiff
Status
Deadline passed
Reported proof requirement
Unclear
Apply as lead plaintiff

Zoetis Lead Plaintiff Application

The article states that investors who purchased Zoetis shares during the alleged class period of January 14, 2025 through May 6, 2026 may contact the law firm regarding the action.

Contact Levi & Korsinsky regarding the lead-plaintiff process. The stated deadline has passed.

Type
Law Firm Signup
Status
Deadline passed
Reported proof requirement
Unclear

Bronstein, Gewirtz & Grossman investor inquiry

Investors who may have purchased Zoetis securities during the alleged class period may contact the law firm regarding the lawsuit; the article does not provide the class-period dates or establish eligibility.

Contact Bronstein, Gewirtz & Grossman using the information provided by the firm.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear

Law Firm Inquiry

Investors seeking information about potential claims were invited to contact Glancy Prongay Wolke & Rotter LLP.

Contact Glancy Prongay Wolke & Rotter LLP by email or telephone using the contact information provided in the article.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear

Investor legal-rights inquiry

Individuals who purchased or acquired Zoetis securities between January 14, 2025, and May 6, 2026.

Contact Bragar Eagel & Squire attorneys Brandon Walker or Melissa Fortunato at (212) 355-4648 to discuss legal rights.

Type
Law Firm Signup
Status
Unknown

This information does not determine whether you qualify for a case.

Sources

Public reporting associated with this case.